CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.

Sabrina KhanAstrid OlesenMessoud Ashina

Published in: Cephalalgia : an international journal of headache (2017)

Efficacy of anti-CGRP monoclonal antibodies spells a promising future for the many patients suffering from migraine, and possibly also for the smaller but severely-affected population with cluster headache.

Keyphrases

systematic review
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
meta analyses
patient reported outcomes
randomized controlled trial
mesenchymal stem cells
patient reported